HOLMES EDWARD W has filed 6 insider transactions across 1 company since August 2023.
Most recent transaction: a grant/award of 15000 shares of Arcturus Therapeutics Holdings Inc. ($ARCT) on June 09, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 9, 2025 | Arcturus Therapeutics Holdings Inc. | $ARCT | HOLMES EDWARD W | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 27,119,823 | 9999.99% | 0.06% |
| June 14, 2024 | Arcturus Therapeutics Holdings Inc. | $ARCT | HOLMES EDWARD W | Director | M | Common Stock | 3131 | $0.00 | 3,131.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Arcturus Therapeutics Holdings Inc. | $ARCT | HOLMES EDWARD W | Director | M | Deferred Stock Units | 3131 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 14, 2024 | Arcturus Therapeutics Holdings Inc. | $ARCT | HOLMES EDWARD W | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Arcturus Therapeutics Holdings Inc. | $ARCT | HOLMES EDWARD W | Director | A | Stock Option (right to buy) | 11869 | $0.00 | 11,869.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Arcturus Therapeutics Holdings Inc. | $ARCT | HOLMES EDWARD W | Director | A | Deferred Stock Units | 3131 | $0.00 | 3,131.0000 | 0 | 9999.99% | 0.00% |